Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) Peptide
Aperçu rapide pour Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) Peptide (ABIN937844)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- EHRLFERLFE DYNEIIRPVA NVSDPVIIHF EVSMSQLVKV DEVNQIMETN
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA3 antibody,
Alternative Names: CHRNA3 control peptide, CHRNA3 antibody Blocking Peptide, Anti-CHRNA3 Blocking Peptide, Cholinergic Receptor Nicotinic Alpha 3 Blocking Peptide, MGC104879 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
-
Sujet
- The CHRNA3 subunit is expressed in the soma of the majority of pyramidal cells, with the most alpha 3 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma.
-
Poids moléculaire
- 57 kDa
Antigène
-